NHS Greater Glasgow and Clyde: Heart Failure trials
The registry lists 15 Heart Failure studies with NHS Greater Glasgow and Clyde as lead sponsor. 5 are open to participants now and 2 have results posted.
Phase 2 2Phase 3 1Phase 4 2No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency DepartmentRecruitingNCT07391280Not applicable
- Biomarkers for the Assessment of Congestion in Patients With Ambulatory and Hospitalised Heart FailureNot yet recruitingNCT06459999
- Correlation of Non-invasive CPM Wearable Device With Measures of Congestion in Heart Failure in ExerciseRecruitingNCT06393842
- Biomarkers in Patients With Suspected HFpEFRecruitingNCT06101693
- Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"RecruitingNCT05919342Not applicable
- RELieving Increasing oEdema Due to Heart FailureTerminatedNCT04142788Phase 4Results posted
- Curing Atrial Fibrillation in Heart FailureCompletedNCT00292162Not applicableResults posted
- Targeted Assessment in High-Risk paTients With dIAbetes to ideNtify Undiagnosed Heart FailureActive, not recruitingNCT05705869Not applicable
- Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart FailureCompletedNCT05419115Phase 2
- Quantifying Congestion by UltrasoundStatus unknownNCT05090137Not applicable
- Correlation of the Non-invasive Cardiopulmonary Management (CPM) Wearable Device With Measures of Congestion in Heart FailureCompletedNCT05026034
- DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTanceStatus unknownNCT04860011Phase 3
- Optimising a Digital Diagnostic Pathway for Heart Failure in the CommunityCompletedNCT04724200
- Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic EffectsCompletedNCT03485092Phase 4
- Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary DiseaseTerminatedNCT00702156Phase 2